CMS Open Payments · Program Year 2024
Nuvascular Inc.
Nuvascular Inc. reported $55,000.00 in payments to 0 physicians and teaching hospitals across 5 transactions.
- $55.0K
- Total payments
- 5
- Transactions
- 0
- Recipients
- #1327
- of 1,925 companies
Nuvascular Inc. reported $55,000.00 in payments to 0 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1327 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $0.00 per recipient across 0 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
The verdict
Nuvascular Inc. posts below-median payment volume among 1,925 companies reporting payments in CMS Open Payments PY2024.
- #1327
- of 1,925 companies
- 0.0%
- of all US industry payments
- 0
- payment categories
How Nuvascular Inc. ranks nationally
Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.
Nuvascular Inc.'s total vs. every reporting company
CMS Open Payments, Program Year 2024
$55,000 31st percentile higher than 31% of 1,925 reporting companies
Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Open Payments · 2024
What the Data Shows for Nuvascular Inc.
Nuvascular Inc. ranks #1327 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $55,000.00 across 5 transactions to 0 physicians and teaching hospitals - $11.0K per transaction and $0.00 per recipient on average.
The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.
Payment Size Analysis
Average transaction size: $11.0K. Average per recipient: $0.00.
Total Amount
$55,000.00
Avg per Transaction
$11.0K
Avg per Recipient
$0.00
Payment Transparency Context
What is the Sunshine Act?
The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.
Industry Total (2024)
$13.9B
across 1,925 companies
Nuvascular Inc. Share
0.0%
#1327 by total payments
Companies with Similar Payment Volumes
Pharmaceutical companies with payment totals similar to Nuvascular Inc.
Frequently Asked Questions
How much did Nuvascular Inc. pay to physicians and hospitals in 2024? ▾
How many physicians received payments from Nuvascular Inc.? ▾
What types of payments did Nuvascular Inc. make? ▾
How does Nuvascular Inc. rank among pharmaceutical companies? ▾
What is the average payment size from Nuvascular Inc.? ▾
Where does the payment data for Nuvascular Inc. come from? ▾
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.